Immunoregulation of murine plasmacytoma. II. Target selectivity of anomalous killer cells and role of immune T cells for the induction.

Abstract:

:Requirements for the induction of anomalous killer (AK) cells to syngeneic MOPC 104E-KI81 plasmacytoma, and their pattern of reaction were investigated. The AK cells are Thy-1.2 positive and were induced by cocultivation of normal BALB/c spleen cells for 5 days in vitro with mitomycin C-treated MOPC 104E-KI81 cells in RPMI 1640 medium supplemented with fetal calf serum and 2-mercaptoethanol. The pattern of reactivity was investigated by direct cytotoxicity and indirect cold target inhibition assays using a panel of target cells. The results from cold target inhibition show that anomalous killer cells react with various tumor targets in the same preferential order as the results shown in direct cytotoxicity assay, and indicates that the AK cell population may be detecting the same determinants expressed to different degrees on panels of target cells. Kinetic study showed that peak cytotoxic responses were observed on day 5 and day 4, for primary and secondary sensitizing cultures, respectively. Cytotoxicity was not generated when nude mouse spleen cells were used as responder cells, suggesting the essential role of T cells in the induction. Nylon wool-column-purified splenic T cells from mice primed in vivo with intraperitoneal injection of MMC-treated stimulator cells, but not from normal mice, were able to generate AK cells in vitro. These results indicate that generation of AK cells with NK-cell-like reactivity needs inductive factors provided by the immune reaction between sensitized T cells and stimulatory MOPC 104E-KI81 cells.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Hayashida I,Hiramoto RN,Shrestha K,Ghanta VK

doi

10.3109/07357908909038265

subject

Has Abstract

pub_date

1989-01-01 00:00:00

pages

27-38

issue

1

eissn

0735-7907

issn

1532-4192

journal_volume

7

pub_type

杂志文章
  • Association between methylation of SHP-1 isoform I and SSTR2A promoter regions with breast and prostate carcinoma development.

    abstract::Methylation pattern is presented here for first time as a potential molecular marker of changes on SSTR2A and SHP-1(I) gene promoter related to breast and prostate carcinoma. Our results have shown low concordances with SSTR2A and methylated state in prostate cancer and moderate relationship with unmethylated CpG-27 i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.1001892

    authors: Tiscornia MM,González HS,Lorenzati MA,Zapata PD

    更新日期:2015-03-01 00:00:00

  • Digital dermatoglyphics in mammary cancer.

    abstract::Fingerprints from 200 women with histologically proven breast cancer (case group) were compared to fingerprints from 138 women with no history of any malignant disease (control group). Of the patterns analyzed, four were significantly associated with breast cancer: accidentals, transitionals, angled ulnar loops, and h...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077025

    authors: Bierman HR,Faith MR,Stewart ME

    更新日期:1988-01-01 00:00:00

  • Apoptosis in lymphocytic leukemias and lymphomas.

    abstract::Most current classifications of lymphoid neoplasms define the tumors based on the cell of origin, phenotype, genetic abnormalities, and clinical features. Here it is proposed that human lymphocytic tumors can be categorized based on the propensity and capacity of the tumor cells to undergo apoptosis. The first categor...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120002951

    authors: Schattner EJ

    更新日期:2002-01-01 00:00:00

  • Necrotic lung and bronchopleural fistula as complications of therapy in lung cancer.

    abstract::Seven patients developed a lung abscess and bronchopleural fistula after undergoing aggressive treatment of their lung cancer with radiotherapy +/- chemotherapy. These complications were preceded by a prodrome of recurrent bronchitis with increasing refractoriness to antibiotics, weight loss, fever, and generalized de...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077041

    authors: Frytak S,Lee RE,Pairolero PC,Arnold PG,Shaw JN

    更新日期:1988-01-01 00:00:00

  • Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma.

    abstract::Like many tumor suppressor genes, some miRNA genes harboring CpG islands undergo methylation-mediated silencing. In the study, we found significant downregulation and proximal promoter methylation of miR-203a and miR-203b in gastric cardia adenocarcinoma (GCA) tissues. The methylation status of miR-203a and miR-203b i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2016.1242010

    authors: Liu W,Dong Z,Liang J,Guo X,Guo Y,Shen S,Kuang G,Guo W

    更新日期:2016-11-25 00:00:00

  • Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.

    abstract::The WORLD07 study characterizes lung cancer in Spanish women. This analysis investigated lung cancer features in never-smoking women. Of 2072 women recruited, 2035 were analyzed. Patient characteristics and demographics were similar for current/former smokers and never smokers. Among never smokers, 38.3% were exposed ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.1080/07357907.2017.1295461

    authors: Viñolas N,Garrido P,Isla D,Provencio M,Majem M,Artal A,Carcereny E,Garcia Campelo R,Lianes P,De La Peñas R,Felip E

    更新日期:2017-05-28 00:00:00

  • Three case reports of hand-foot syndrome with gefitinib.

    abstract::Hand-Foot Syndrome (HFS) is commonly reported in treatment with liposomal doxorubicin (LD) and capecitabine. We present 3 cases of HFS recall with gefitinib after previous LD therapy. The first 2 cases, in patients with head and neck cancer previously treated with paclitaxel and LD, developed on subsequent therapy wit...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900600814847

    authors: Razis E,Karina M,Karanastassi S,Fountzilas G

    更新日期:2006-08-01 00:00:00

  • Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.

    abstract::We analyzed the pattern of alpha-fetoprotein (AFP) synthesis in 40 consecutive human hepatocarcinomas (HCC) in relation to hepatitis B viral (HBV) infection. In addition, histopathological characteristics of liver parenchyma and the tumor itself were examined. Elevated AFP (> 20 ng/ml) were found in 90% of HCC patient...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909209024813

    authors: Kashala LO,Kalengayi MM,Essex M

    更新日期:1992-01-01 00:00:00

  • Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.

    abstract::The interaction of 5-fluorouracil and cyclophosphamide in the treatment of L1210 and P388 leukemias was studied using response surface methodology. Single dose treatment of each drug was administered simultaneously or with a 24-hr interval between 5-fluorouracil and cyclophosphamide to the advanced tumors or at variou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908709020311

    authors: Wampler GL,Carter WH Jr,Campbell ED

    更新日期:1987-01-01 00:00:00

  • A novel 3-d model of chick chorioallantoic membrane for ameliorated studies in angiogenesis.

    abstract::Decisive indulgence of angiogenesis requires a more holistic assessment and several in vivo assays have been developed that permit a more realistic appraisal of the angiogenic response. One of the most popular assays to study angiogenic activity is the chick chorioallantoic membrane (CAM). Although CAM assay is a vita...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900600894773

    authors: Ejaz S,Chekarova I,Ashraf M,Lim CW

    更新日期:2006-10-01 00:00:00

  • A phase I trial of chlorambucil administered in short pulses in patients with advanced malignancies.

    abstract::We carried out a phase I trial with chlorambucil. Thirty patients with advanced cancer were entered in six dose levels: 36, 48, 60, 84, 108, and 144 mg/m2. The drug was given in six divided oral doses every 6 hours and the regimen was repeated every 3 weeks. The median age was 62 years (31-84), median Karnofsky perfor...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809080064

    authors: Blumenreich MS,Woodcock TM,Sherrill EJ,Richman SP,Gentile PS,Epremian BE,Kubota TT,Allegra JC

    更新日期:1988-01-01 00:00:00

  • Clinical cancer research, DNR orders, and medical economics: a complex interrelationship.

    abstract::Despite the dramatic success achieved over the past few years in improving the survival of individuals with cancer, treatment for many patients with advanced malignancies remains far from satisfactory. Unfortunately, centers engaged in clinical cancer research are currently faced with the dilemma of dealing with incre...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357908709011740

    authors: Markman M

    更新日期:1987-01-01 00:00:00

  • Role of CA125 and abdominal pelvic computerized axial tomogram in the monitoring of chemotherapy treatment of ovarian cancer.

    abstract::Twenty four patients with epithelial ovarian cancer, who were treated by chemotherapy after debulking surgery, were monitored by serial monthly CA125 estimation and half-yearly computerized axial tomogram (CAT) of abdomen and pelvis. The efficiency of these monitoring methods and that of clinical examination were comp...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909009012069

    authors: Ngan HY,Wong LC,Chan SY,Ma HK

    更新日期:1990-01-01 00:00:00

  • Type 2 Diabetes Associated with Abnormal p53 Immunohistochemical Patterns in Colorectal Cancer.

    abstract::Abnormal p53 immunohistochemical pattern (p53-AP) including overexpression, complete absence and heterogeneity is surrogate of TP53 mutation. Using 742 cases of colorectal cancer (CRC), we show p53-AP is more common among type 2 diabetes (T2DM) patients than non-T2DM. Univariately, T2DM was significantly associated wi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1852411

    authors: Yang Z,Ma J,Qi G,Zhang X

    更新日期:2021-01-01 00:00:00

  • Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells.

    abstract::Drug resistance to TKIs and the existance of CML leukemia stem cells is an urgent problem. In this study, we demonstrate that quinacrine (QC) induces apoptosis in BCR-ABL positive CML and acute lymphoblastic leukemia (ALL) cells. Interestingly, QC inhibits the colony formation of primary CD34+ progenitor/stem leukemia...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1630633

    authors: Lei H,Tu Y,Yang L,Jin J,Luo H,Xu H,Kang J,Zhou L,Wu Y

    更新日期:2019-01-01 00:00:00

  • Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities.

    abstract::Inflammation plays a role in the pathogenesis of endometriosis. Endometriosis-associated ovarian carcinogenesis might be promoted through oxidative stress-induced increased genomic instability, aberrant methylation, and aberrant chromatin remodeling, as well as mutations of tumor suppressor genes. Aberrant expression ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2012.681821

    authors: Shigetomi H,Tsunemi T,Haruta S,Kajihara H,Yoshizawa Y,Tanase Y,Furukawa N,Yoshida S,Sado T,Kobayashi H

    更新日期:2012-07-01 00:00:00

  • A phase I study of gemcitabine and docetaxel for advanced stage solid tumors.

    abstract:BACKGROUND:We conducted a phase I study to determine the maximum tolerated dose of docetaxel in combination with gemcitabine for patients with refractory solid tumors. METHODS:From January 1998 to November 1999, we treated 28 patients on a phase I protocol with gemcitabine given at a constant dose of 800 mg/m2 i.v. ov...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120018225

    authors: Poole ME,Bernard SA,Churchel MA,Weissler MC,Calvo B,Cance W,Ollila D,Koruda M,Behrns K,Detterbeck FC

    更新日期:2003-06-01 00:00:00

  • Computer visualization techniques (CVTs) foster evidence-based target delineation.

    abstract::Computer visualization techniques (CVTs) are an emerging technology that can organize all cancer specialists. This article describes CVTs' ability to maximize the currently untapped advantages of intensity modulated radiotherapy (IMRT). The visual speed and dynamic strategies inherent in CVTs improves IMRT by distilli...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900600970490

    authors: Butler EB,Shukla V,Paulino AC,Lu HH,Butler R,Smiedala M,Kurk J,Grant WH 3rd,McGary JE,Teh BS

    更新日期:2007-02-01 00:00:00

  • Signal transduction pathways involved in the lineage-differentiation of NSCs: can the knowledge gained from blood be used in the brain?

    abstract::Neural stem cells (NSC) are capable of differentiating toward neuronal, astrocytic, oligodendrocytic and glial lineages, depending on their spatial location within the central nervous system (CNS). Although, a lot of knowledge has been gained in the understanding of differentiation-specific signaling in hematopoietic ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200039679

    authors: Mondal D,Pradhan L,LaRussa VF

    更新日期:2004-01-01 00:00:00

  • Abnormal liver function in patients undergoing autologous bone marrow transplantation for hematological malignancies.

    abstract::Autologous bone marrow transplantation (AuBMT) is an accepted treatment modality for patients with high-risk or relapsed hematological malignancies. Hepatotoxicity, in particular veno-occlusive disease (VOD), is a significant complication of this therapy. The purpose of this study was to determine the clinical relevan...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509031914

    authors: Wasserheit C,Acaba L,Gulati S

    更新日期:1995-01-01 00:00:00

  • Immune signatures predict prognosis in localized cancer.

    abstract::The host immune response can impact cancer growth, prognosis, and response to therapy. In colorectal cancer, the presence of cells involved with T-cell-mediated adaptive immunity predicts survival better than the current staging method. We used the expression of genes recently associated with host immune responses (T(...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903095755

    authors: Hsu DS,Kim MK,Balakumaran BS,Acharya CR,Anders CK,Clay T,Lyerly HK,Drake CG,Morse MA,Febbo PG

    更新日期:2010-08-01 00:00:00

  • Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotype.

    abstract:BACKGROUND:This study examined a PERIOD3 (PER3) gene variable number tandem repeat polymorphism and chronotype as potential BrCA risk factors among Indian women. METHODS:This case-control study included sporadic, histologically confirmed BrCA cases (n = 255) and controls (n = 249) from India with data collection from ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.919305

    authors: Wirth MD,Burch JB,Hébert JR,Kowtal P,Mehrotra-Kapoor A,Steck SE,Hurley TG,Gupta PC,Pednekar MS,Youngstedt SD,Zhang H,Sarin R

    更新日期:2014-08-01 00:00:00

  • Experimental basis for cancer prevention by vitamin E.

    abstract::Recent clinical trials have demonstrated the significant cancer preventive potential of vitamin E in many different cancer sites, ranging from oral and pharyngeal cancer to prostate cancer. There is an extensive experimental basis for this clinical cancer inhibition. The experimental background includes animal studies...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357900009031826

    authors: Shklar G,Oh SK

    更新日期:2000-01-01 00:00:00

  • Trends in Survival Based on Treatment Modality in Non-Small Cell Lung Cancer Patients: A Population-Based Study.

    abstract::Objectives: We examined the trends in survival based on treatment modality among non-small cell lung cancer (NSCLC) patients in the province of Ontario, Canada, from 2007 to 2015. Methods: We investigated the trends in survival based on treatment modality. Results: Among 56,417 identified patients, the mean age at dia...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1653465

    authors: Akhtar-Danesh N,Akhtar-Danseh GG,Seow HY,Shakeel S,Finley C

    更新日期:2019-01-01 00:00:00

  • The problem of post-breast cancer lymphedema: impact and measurement issues.

    abstract::Breast cancer treatment is recognized as the most common cause of secondary lymphedema (LE) in the developed countries of the world. LE occurs as both an acute and chronic health condition in which significant and persistent swelling is associated with an abnormal accumulation of protein-rich fluid. The impact of LE i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:

    authors: Armer JM

    更新日期:2005-01-01 00:00:00

  • Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review.

    abstract::Malignant kidney tumors account for approximately 2% of all new primary cancer cases diagnosed in the United States, with an estimated 30,000 cases occurring annually. Although a variety of agents, chemical and biological, have been implicated as causal agents in the development of renal cell carcinoma (RCC), the etio...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200055962

    authors: Moore LE,Wilson RT,Campleman SL

    更新日期:2005-01-01 00:00:00

  • Effect of plasma fibronectin, macrophages, and glycosaminoglycans on tumor cell growth.

    abstract::Fibronectin (Fn) synergizes with macrophages (M phi) in inducing cytostasis and cytotoxicity of neoplastic cells in culture. Since heparin enhances Fn's opsonic activity in many systems, we investigated its effect on Fn-macrophage synergy in cytostasis. MCG-T14 (a spontaneous mouse mammary adenocarcinoma) cells (4 X 1...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908409040310

    authors: Martin DE,Reece M,Reese AC

    更新日期:1984-01-01 00:00:00

  • Ab initio studies of some amino acid residue complexes with 4-mercaptopyridine as a model for thymitaq (AG337), an inhibitor of thymidylate synthase.

    abstract::The complex formed by isopentane, as a model for the isoleucine residue present in the wild-type thymidylate synthase, with 4-mercaptopyridine as a fragment of the thymidylate synthase inhibitor Thymitaq (AG337) is investigated with ab initio quantum chemical calculations at Hartree-Fock and MP2 levels, using the 3-21...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909909021431

    authors: Sapse DS,Tong Y,Bertino JR,Sapse AM

    更新日期:1999-01-01 00:00:00

  • Introduction to genetic linkage analysis.

    abstract::Advances in molecular methodology have resulted in the successful genetic mapping and isolation of the genes responsible for numerous simple Mendelian disorders such as cystic fibrosis, neurofibromatosis, and Huntington disease. Recently, researchers have begun to successfully study diseases with more complex inherita...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909709047596

    authors: Foroud T

    更新日期:1997-01-01 00:00:00

  • A phase I trial to determine the safety of imatinib in combination with vatalanib in patients with advanced malignancies.

    abstract::The role of tyrosine kinase inhibitors (TKIs) in the treatment of advanced malignancies is well established. Imatinib and vatalanib are oral TKIs with different mechanisms of action. This trial sought to establish the safety, tolerability, and maximum tolerated dose (MTD) of the two agents in combination. Secondary ob...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.568567

    authors: Spigel D,Jones S,Hainsworth J,Infante J,Greco FA,Thompson D,Doss H,Burris H

    更新日期:2011-05-01 00:00:00